Arcutis Biotherapeutics Clinical Site 64

San Diego, California 92123

0 studies enrolling now · 3 studies all time

What they study most

Scalp Psoriasis, Seborrheic Dermatitis

Studies at this site

• Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) — Completed
• Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis — Completed
• Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) — Completed